Halozyme Therapeutics, Inc. (HALO)

67.69 -1.26 (-1.83%) USD  |  NASDAQ  |  Dec 30, 16:00
67.51 -0.18 (-0.27%) After-Hours: 17:42
More

Halozyme Therapeutics EV to Revenues

EV to Revenues Chart

View EV to Revenues for HALO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to Revenues Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EV to Revenues Range, Past 5 Years

View EV to Revenues Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to Revenues Benchmarks

View EV to Revenues Benchmarks
Start Trial
Johnson & Johnson Upgrade
Merck & Co., Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
Protalix Biotherapeutics, Inc. Upgrade

EV to Revenues Related Metrics

EV to CFO Upgrade
EV to EBITDA Upgrade
EV to EBIT Upgrade
EV to Free Cash Flow Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade